Read more: https://2019.synbiobeta.com/
Follow us on LinkedIn or Twitter @ActobioT for more updates.
Dr. Steidler has been invited to talk about the innovative ActoBiotics® platform and its applications. For more information please visit www.microbiome-summit.com.
Make an appointment for a chat via the partnerONE platform to discuss opportunities for the ActoBiotics® technology.
For more updates follow us on LinkedIn or Twitter @ActoBioT.
Chief Executive Officer Pieter Rottiers has been invited to participate in a panel discussion entitled “Evaluation of Combination Therapies to Address Unmet Clinical Needs” on Thursday 28th March at 16:30. For more information please visit www.as-immunetolerance.com.